ZL-6201 is a novel ADC with an internally developed high affinity and specificity for LRRC15 antibody and next-generation ... including thyroid eye disease, myositis, seronegative gMG, ocular ...

Recovery: without specific therapy, begins 2–4 weeks after progression ... There is the same paucity of lymphocytic inflammation consistent with an antibody-mediated pathogenesis.65 66 Guillain-Barré ...

B-cell maturation antigen (BCMA)-directed bispecific antibodies have tolerable safety profiles in frail patients with relapsed/refractory multiple myeloma (MM), according to a real-world study ...

The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...

Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, ...

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma (NHL). The decision throws a ...

Crimean–Congo hemorrhagic fever (CCHF) caused by the CCHF virus, a member of the family Bunyaviridae, genus Nairovirus, is a tick-borne acute viral hemorrhagic fever with a high case–fatality ...

A football player was diagnosed with myositis ossificans of his right adductor longus ... it was possible to distinguish MOT from all these other diagnoses through the combination of the specific ...

In this episode, host Shikha Jain, MD, speaks with Abiola Ibraheem, MD, about the role culture plays in improving global oncology, launching the Best of ASCO in Africa and more.